_id
69148175ccc777a4e85d9328
Ticker
NGENF
Name
NervGen Pharma Corp
Exchange
OTCQB
Address
112-970 Burrard Street, Vancouver, BC, Canada, V6Z 2R4
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.nervgen.com
Description
NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company's lead product candidate is NVG-291 that is in Phase 1b/2a clinical trial for the treatment of spinal cord injuries (SCI), stroke, multiple sclerosis, and Alzheimer's disease; and NVG-300, which is in a preclinical model of ischemic stroke and confirmatory SCI study. NervGen Pharma Corp. has a licensing agreement with Case Western Reserve University to develop and commercialize a patented technology with therapeutic potential for spinal cord injury and other conditions associated with nerve damage. The company was incorporated in 2017 and is based in Vancouver, Canada.
Last Close
5.6
Volume
23685
Current Price
5.75
Change
0.2
Last Updated
2026-01-05T11:22:01.114Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
465769568
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
6170687
Operating Income
-6170687
Interest Expense
-
Pretax Income
-4156070
Net Income
-4156070
Eps
-0.05661619604883095
Dividends Per Share
-
Shares Outstanding
79212514
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
1937546
Cash
11364055
Short Term Investments
33225
Receivables
-
Inventories
-
Total Current Assets
12654340
Property Plant Equipment
-
Total Assets
13077452
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
16019155
Equity
-2941703
Bs_currency_symbol
CAD
Depreciation
13949
Change In Working Capital
-298913
Cash From Operations
-5318049
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
995203
Net Change In Cash
-4310568
Cf_currency_symbol
CAD
PE
-
PB
-143.48654835311385
ROE
141.28108785965136
ROA
-31.780426339932273
FCF
-5318049
Fcf Percent
-
Piotroski FScore
0
Health Score
38
Deep Value Investing Score
1
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
3
Net Net Investing Score
0.5
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
6170687
Quarters > 0 > income Statement > operating Income
-6170687
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-4156070
Quarters > 0 > income Statement > net Income
-4156070
Quarters > 0 > income Statement > eps
-0.05661619604883095
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
73407793
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1937546
Quarters > 0 > income Statement > currency_symbol
CAD
Quarters > 0 > balance Sheet > cash
11364055
Quarters > 0 > balance Sheet > short Term Investments
33225
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
12654340
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
13077452
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
16019155
Quarters > 0 > balance Sheet > equity
-2941703
Quarters > 0 > balance Sheet > currency_symbol
CAD
Quarters > 0 > cash Flow > net Income
-4156070
Quarters > 0 > cash Flow > depreciation
13949
Quarters > 0 > cash Flow > change In Working Capital
-298913
Quarters > 0 > cash Flow > cash From Operations
-5318049
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
995203
Quarters > 0 > cash Flow > net Change In Cash
-4310568
Quarters > 0 > cash Flow > currency_symbol
CAD
Quarters > 0 > ratios > PE
-0.05661619604883095
Quarters > 0 > ratios > PB
-143.48654835311385
Quarters > 0 > ratios > ROE
141.28108785965136
Quarters > 0 > ratios > ROA
-31.780426339932273
Quarters > 0 > ratios > FCF
-5318049
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
6469000
Quarters > 1 > income Statement > operating Income
-6469000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-9104187
Quarters > 1 > income Statement > net Income
-9104187
Quarters > 1 > income Statement > eps
-0.12499606306185462
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
72835790
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-2722091
Quarters > 1 > income Statement > currency_symbol
CAD
Quarters > 1 > balance Sheet > cash
15674623
Quarters > 1 > balance Sheet > short Term Investments
57713
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
16486574
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
16923635
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
17842056
Quarters > 1 > balance Sheet > equity
-918421
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
-9104190
Quarters > 1 > cash Flow > depreciation
13948
Quarters > 1 > cash Flow > change In Working Capital
793527
Quarters > 1 > cash Flow > cash From Operations
-3665048
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
4752484
Quarters > 1 > cash Flow > net Change In Cash
1203326
Quarters > 1 > cash Flow > currency_symbol
CAD
Quarters > 1 > ratios > PE
-0.12499606306185462
Quarters > 1 > ratios > PB
-456.0063331522254
Quarters > 1 > ratios > ROE
991.2868934834895
Quarters > 1 > ratios > ROA
-53.79569460107122
Quarters > 1 > ratios > FCF
-3665048
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
6035282
Quarters > 2 > income Statement > operating Income
-6035282
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-3948192
Quarters > 2 > income Statement > net Income
-3948192
Quarters > 2 > income Statement > eps
-0.05565721525391968
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
70937649
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
1979329
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
14471297
Quarters > 2 > balance Sheet > short Term Investments
81838
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
15387748
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
15838757
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
14449280
Quarters > 2 > balance Sheet > equity
1389477
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
-3948190
Quarters > 2 > cash Flow > depreciation
13949
Quarters > 2 > cash Flow > change In Working Capital
355545
Quarters > 2 > cash Flow > cash From Operations
-4118684
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
1274376
Quarters > 2 > cash Flow > net Change In Cash
-2796192
Quarters > 2 > cash Flow > currency_symbol
CAD
Quarters > 2 > ratios > PE
-0.05565721525391968
Quarters > 2 > ratios > PB
293.5575628455887
Quarters > 2 > ratios > ROE
-284.1495037341388
Quarters > 2 > ratios > ROA
-24.927410654762873
Quarters > 2 > ratios > FCF
-4118684
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
16
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
6805640
Quarters > 3 > income Statement > operating Income
-6805640
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-8608651
Quarters > 3 > income Statement > net Income
-8608651
Quarters > 3 > income Statement > eps
-0.12239820230429324
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
70333149
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-1974121
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
17267489
Quarters > 3 > balance Sheet > short Term Investments
97234
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
19012896
Quarters > 3 > balance Sheet > property Plant Equipment
0
Quarters > 3 > balance Sheet > total Assets
19486223
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
16909616
Quarters > 3 > balance Sheet > equity
2576607
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
-8608651
Quarters > 3 > cash Flow > depreciation
15811
Quarters > 3 > cash Flow > change In Working Capital
743292
Quarters > 3 > cash Flow > cash From Operations
-3659769
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
310000
Quarters > 3 > cash Flow > net Change In Cash
-3740726
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
-0.12239820230429324
Quarters > 3 > ratios > PB
156.95665142181173
Quarters > 3 > ratios > ROE
-334.1080343257625
Quarters > 3 > ratios > ROA
-44.17814062786821
Quarters > 3 > ratios > FCF
-3659769
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
17
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
24931995
Annuals > 0 > income Statement > operating Income
-24931995
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-24005895
Annuals > 0 > income Statement > net Income
-24005895
Annuals > 0 > income Statement > eps
-0.3413169371955747
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
70333149
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
113483
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
17267489
Annuals > 0 > balance Sheet > short Term Investments
97234
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
19012896
Annuals > 0 > balance Sheet > property Plant Equipment
0
Annuals > 0 > balance Sheet > total Assets
19486223
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
16909616
Annuals > 0 > balance Sheet > equity
2576607
Annuals > 0 > balance Sheet > currency_symbol
CAD
Annuals > 0 > cash Flow > net Income
-24005895
Annuals > 0 > cash Flow > depreciation
83798
Annuals > 0 > cash Flow > change In Working Capital
838556
Annuals > 0 > cash Flow > cash From Operations
-16841034
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
22695111
Annuals > 0 > cash Flow > net Change In Cash
5607945
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
-0.3413169371955747
Annuals > 0 > ratios > PB
158.3214918689579
Annuals > 0 > ratios > ROE
-931.6863223611516
Annuals > 0 > ratios > ROA
-123.19419212230096
Annuals > 0 > ratios > FCF
-16841034
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
8
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
17776710
Annuals > 1 > income Statement > operating Income
-17776710
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-22382120
Annuals > 1 > income Statement > net Income
-22382120
Annuals > 1 > income Statement > eps
-0.3754986104763685
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
59606399
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-5155484
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
11659544
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
250209
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
12515486
Annuals > 1 > balance Sheet > property Plant Equipment
199782
Annuals > 1 > balance Sheet > total Assets
13236021
Annuals > 1 > balance Sheet > payables
550401
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
15245126
Annuals > 1 > balance Sheet > equity
-2009105
Annuals > 1 > balance Sheet > currency_symbol
CAD
Annuals > 1 > cash Flow > net Income
-22382120
Annuals > 1 > cash Flow > depreciation
145002
Annuals > 1 > cash Flow > change In Working Capital
-240348
Annuals > 1 > cash Flow > cash From Operations
-11295594
Annuals > 1 > cash Flow > capital Expenditures
141403
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
766285
Annuals > 1 > cash Flow > net Change In Cash
-10792055
Annuals > 1 > cash Flow > currency_symbol
CAD
Annuals > 1 > ratios > PE
-0.3754986104763685
Annuals > 1 > ratios > PB
-172.0751848211019
Annuals > 1 > ratios > ROE
1114.034358582553
Annuals > 1 > ratios > ROA
-169.10006413558878
Annuals > 1 > ratios > FCF
-11436997
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
23025033
Annuals > 2 > income Statement > operating Income
-23025033
Annuals > 2 > income Statement > interest Expense
514599
Annuals > 2 > income Statement > pretax Income
-20722283
Annuals > 2 > income Statement > net Income
-20722283
Annuals > 2 > income Statement > eps
-0.35314603454219357
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
58679076
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-20092570
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
2615953
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
22451599
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
27027
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
23148534
Annuals > 2 > balance Sheet > property Plant Equipment
295280
Annuals > 2 > balance Sheet > total Assets
23875217
Annuals > 2 > balance Sheet > payables
2001916
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
10414137
Annuals > 2 > balance Sheet > equity
13461080
Annuals > 2 > balance Sheet > currency_symbol
CAD
Annuals > 2 > cash Flow > net Income
-20722283
Annuals > 2 > cash Flow > depreciation
115114
Annuals > 2 > cash Flow > change In Working Capital
2114962
Annuals > 2 > cash Flow > cash From Operations
-17784163
Annuals > 2 > cash Flow > capital Expenditures
21105
Annuals > 2 > cash Flow > cash From Investing
-21105
Annuals > 2 > cash Flow > cash From Financing
22641435
Annuals > 2 > cash Flow > net Change In Cash
5522742
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.35314603454219357
Annuals > 2 > ratios > PB
25.28316010305265
Annuals > 2 > ratios > ROE
-153.94220226014554
Annuals > 2 > ratios > ROA
-86.7941137456468
Annuals > 2 > ratios > FCF
-17805268
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
22
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
11377327
Annuals > 3 > income Statement > operating Income
-11377327
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-12726578
Annuals > 3 > income Statement > net Income
-12726578
Annuals > 3 > income Statement > eps
-0.2755291755820966
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
46189584
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-11334701
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
55229
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
16928857
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
64002
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
17420436
Annuals > 3 > balance Sheet > property Plant Equipment
2691
Annuals > 3 > balance Sheet > total Assets
17896279
Annuals > 3 > balance Sheet > payables
352546
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1078080
Annuals > 3 > balance Sheet > equity
16818199
Annuals > 3 > balance Sheet > currency_symbol
CAD
Annuals > 3 > cash Flow > net Income
-12726578
Annuals > 3 > cash Flow > depreciation
42626
Annuals > 3 > cash Flow > change In Working Capital
430499
Annuals > 3 > cash Flow > cash From Operations
-8269157
Annuals > 3 > cash Flow > capital Expenditures
2749
Annuals > 3 > cash Flow > cash From Investing
-45085
Annuals > 3 > cash Flow > cash From Financing
19613162
Annuals > 3 > cash Flow > net Change In Cash
11330297
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.2755291755820966
Annuals > 3 > ratios > PB
15.929148370761935
Annuals > 3 > ratios > ROE
-75.67146755725747
Annuals > 3 > ratios > ROA
-71.11298387782176
Annuals > 3 > ratios > FCF
-8271906
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
27
Valuation > metrics > PE
-0.05661619604883095
Valuation > metrics > PB
-143.48654835311385
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
141.28108785965136
Profitability > metrics > ROA
-32.843040411431964
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-3.1847950964777096
Risk > final Score
17
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
55
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
20
Prev Risks > 1
-6
Prev Risks > 2
-8
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2026-01-20T22:16:39.308Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-02
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-0.06
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-20
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0412
Earnings History > 1 > eps Estimate
-0.06
Earnings History > 1 > eps Difference
0.0188
Earnings History > 1 > surprise Percent
31.3333
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-28
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0914
Earnings History > 2 > eps Estimate
-0.07
Earnings History > 2 > eps Difference
-0.0214
Earnings History > 2 > surprise Percent
-30.5714
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-14
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
CAD
Earnings History > 3 > eps Actual
-0.0389
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2024-12-31
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.0875
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-07
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
CAD
Earnings History > 5 > eps Actual
-0.0547
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-09
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
CAD
Earnings History > 6 > eps Actual
-0.0818
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-16
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
CAD
Earnings History > 7 > eps Actual
-0.0289
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2023-12-31
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
CAD
Earnings History > 8 > eps Actual
-0.106
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-09-30
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
CAD
Earnings History > 9 > eps Actual
-0.054
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-06-30
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
CAD
Earnings History > 10 > eps Actual
-0.0599
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-03-31
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
CAD
Earnings History > 11 > eps Actual
-0.0591
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2022-12-31
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
CAD
Earnings History > 12 > eps Actual
-0.0744
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-14
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
CAD
Earnings History > 13 > eps Actual
-0.08
Earnings History > 13 > eps Estimate
-0.14
Earnings History > 13 > eps Difference
0.06
Earnings History > 13 > surprise Percent
42.8571
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-10
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
CAD
Earnings History > 14 > eps Actual
-0.13
Earnings History > 14 > eps Estimate
-0.11
Earnings History > 14 > eps Difference
-0.02
Earnings History > 14 > surprise Percent
-18.1818
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-12
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
CAD
Earnings History > 15 > eps Actual
-0.11
Earnings History > 15 > eps Estimate
-0.08
Earnings History > 15 > eps Difference
-0.03
Earnings History > 15 > surprise Percent
-37.5
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-28
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
CAD
Earnings History > 16 > eps Actual
-0.09
Earnings History > 16 > eps Estimate
-0.09
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
0
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-18
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
CAD
Earnings History > 17 > eps Actual
-0.09
Earnings History > 17 > eps Estimate
-0.07
Earnings History > 17 > eps Difference
-0.02
Earnings History > 17 > surprise Percent
-28.5714
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-19
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
CAD
Earnings History > 18 > eps Actual
-0.0708
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.0708
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-20
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
CAD
Earnings History > 19 > eps Actual
-0.0586
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.0586
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-31
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
CAD
Earnings History > 20 > eps Actual
-0.0504
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.0504
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-12-31
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
CAD
Earnings History > 21 > eps Actual
-0.102
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.102
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-09-30
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
CAD
Earnings History > 22 > eps Actual
-0.0479
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.0479
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-06-30
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
CAD
Earnings History > 23 > eps Actual
-0.0637
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-03-31
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
CAD
Earnings History > 24 > eps Actual
-0.0449
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-12-31
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
CAD
Earnings History > 25 > eps Actual
-0.0774
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-09-30
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
CAD
Earnings History > 26 > eps Actual
-0.0632
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-06-30
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
CAD
Earnings History > 27 > eps Actual
-0.0421
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
-0.0421
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2019-03-31
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
CAD
Earnings History > 28 > eps Actual
-0.1171
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
-0.1171
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-12-31
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
CAD
Earnings History > 29 > eps Actual
-0.0325
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
-0.0325
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-09-30
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
CAD
Earnings History > 30 > eps Actual
-0.0311
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
-0.0311
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-06-30
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
CAD
Earnings History > 31 > eps Actual
-0.0268
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
-0.0268
Earnings History > 31 > surprise Percent
-
NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company's lead product candidate is NVG-291 that is in Phase 1b/2a clinical trial for the treatment of spinal cord injuries (SCI), stroke, multiple sclerosis, and Alzheimer's disease; and NVG-300, which is in a preclinical model of ischemic stroke and confirmatory SCI study. NervGen Pharma Corp. has a licensing agreement with Case Western Reserve University to develop and commercialize a patented technology with therapeutic potential for spinal cord injury and other conditions associated with nerve damage. The company was incorporated in 2017 and is based in Vancouver, Canada.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ANervGen Pharma (OTCQB: NGENF) Proposes C$2.44 vs US$1.75 Warrant Exercise Price - Stock Titan
12/12/2025
NervGen Pharma (OTCQB: NGENF) Proposes C$2.44 vs US$1.75 Warrant Exercise Price Stock Titan
Read more →NervGen Pharma Announces Closing of US$10 Million Non-Brokered Private Placement to Support Anticipated Nasdaq Listing and Advance NVG-291 Development TMX Newsfile
Read more →Showing 2 of 9
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of NervGen Pharma Corp
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
-0.06
Date
2025-09-30
EPS Actual
-0.0412
EPS Estimate
-0.06
EPS Difference
0.0188
Surprise Percent
31.3333%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.